메뉴 건너뛰기




Volumn 14, Issue 1, 2014, Pages

Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs

Author keywords

Camptothecin; Chemokine; Colon cancer; Cytokine; Drug response; NF B

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; ERLOTINIB; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; OXALIPLATIN; PHLEOMYCIN; PROTEIN BCL XL; PROTEIN P53; SM 7368; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; PLATINUM COMPLEX; QUINAZOLINE DERIVATIVE;

EID: 84906824159     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-599     Document Type: Article
Times cited : (29)

References (44)
  • 1
    • 84874144193 scopus 로고    scopus 로고
    • Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance
    • Gonzalez de Castro D, Clarke PA, Al-Lazikani B, Workman P. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance. Clin Pharmacol Ther 2013, 93(3):252-259.
    • (2013) Clin Pharmacol Ther , vol.93 , Issue.3 , pp. 252-259
    • Gonzalez de Castro, D.1    Clarke, P.A.2    Al-Lazikani, B.3    Workman, P.4
  • 3
    • 84892547340 scopus 로고    scopus 로고
    • Essential elements of personalized medicine
    • Burke W, Brown Trinidad S, Press NA. Essential elements of personalized medicine. Urol Oncol 2014, 32(2):193-197.
    • (2014) Urol Oncol , vol.32 , Issue.2 , pp. 193-197
    • Burke, W.1    Brown Trinidad, S.2    Press, N.A.3
  • 4
    • 77955620636 scopus 로고    scopus 로고
    • Personalized medicine in oncology: tailoring the right drug to the right patient
    • Jiang Y, Wang M. Personalized medicine in oncology: tailoring the right drug to the right patient. Biomark Med 2010, 4(4):523-533.
    • (2010) Biomark Med , vol.4 , Issue.4 , pp. 523-533
    • Jiang, Y.1    Wang, M.2
  • 5
    • 84898602164 scopus 로고    scopus 로고
    • Towards defining biomarkers indicating resistances to targeted therapies
    • Stehle F, Schulz K, Seliger B. Towards defining biomarkers indicating resistances to targeted therapies. Biochim Biophys Acta 2014, 1844(5):909-916.
    • (2014) Biochim Biophys Acta , vol.1844 , Issue.5 , pp. 909-916
    • Stehle, F.1    Schulz, K.2    Seliger, B.3
  • 6
    • 84865254848 scopus 로고    scopus 로고
    • Mechanisms of acquired resistance to targeted cancer therapies
    • Lackner MR, Wilson TR, Settleman J. Mechanisms of acquired resistance to targeted cancer therapies. Future Oncol 2012, 8(8):999-1014.
    • (2012) Future Oncol , vol.8 , Issue.8 , pp. 999-1014
    • Lackner, M.R.1    Wilson, T.R.2    Settleman, J.3
  • 7
    • 84883639819 scopus 로고    scopus 로고
    • Mechanisms of targeted therapy resistance take a de-TOR
    • Gentry LR, Martin TD, Der CJ. Mechanisms of targeted therapy resistance take a de-TOR. Cancer Cell 2013, 24(3):284-286.
    • (2013) Cancer Cell , vol.24 , Issue.3 , pp. 284-286
    • Gentry, L.R.1    Martin, T.D.2    Der, C.J.3
  • 8
    • 73649112422 scopus 로고    scopus 로고
    • Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation
    • Takahashi H, Ogata H, Nishigaki R, Broide DH, Karin M. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 2010, 17(1):89-97.
    • (2010) Cancer Cell , vol.17 , Issue.1 , pp. 89-97
    • Takahashi, H.1    Ogata, H.2    Nishigaki, R.3    Broide, D.H.4    Karin, M.5
  • 9
    • 70449109147 scopus 로고    scopus 로고
    • Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma
    • Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, Ouyang C, Jacks T. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 2009, 462(7269):104-107.
    • (2009) Nature , vol.462 , Issue.7269 , pp. 104-107
    • Meylan, E.1    Dooley, A.L.2    Feldser, D.M.3    Shen, L.4    Turk, E.5    Ouyang, C.6    Jacks, T.7
  • 10
    • 33745298519 scopus 로고    scopus 로고
    • Nuclear factor-kappaB in cancer development and progression
    • Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441(7092):431-436.
    • (2006) Nature , vol.441 , Issue.7092 , pp. 431-436
    • Karin, M.1
  • 12
    • 44349096269 scopus 로고    scopus 로고
    • Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity
    • Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Br J Cancer 2008, 98(11):1781-1783.
    • (2008) Br J Cancer , vol.98 , Issue.11 , pp. 1781-1783
    • Wernli, K.J.1    Newcomb, P.A.2    Hampton, J.M.3    Trentham-Dietz, A.4    Egan, K.M.5
  • 14
    • 0034044516 scopus 로고    scopus 로고
    • Colorectal cancer chemoprevention: aspirin, other NSAID and COX-2 inhibitors
    • Kune GA. Colorectal cancer chemoprevention: aspirin, other NSAID and COX-2 inhibitors. Aust N Z J Surg 2000, 70(6):452-455.
    • (2000) Aust N Z J Surg , vol.70 , Issue.6 , pp. 452-455
    • Kune, G.A.1
  • 17
    • 3142717392 scopus 로고    scopus 로고
    • NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer
    • Altinoz MA, Korkmaz R. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma 2004, 51(4):239-247.
    • (2004) Neoplasma , vol.51 , Issue.4 , pp. 239-247
    • Altinoz, M.A.1    Korkmaz, R.2
  • 18
    • 0032508414 scopus 로고    scopus 로고
    • NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
    • Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281(5383):1680-1683.
    • (1998) Science , vol.281 , Issue.5383 , pp. 1680-1683
    • Wang, C.Y.1    Mayo, M.W.2    Korneluk, R.G.3    Goeddel, D.V.4    Baldwin, A.S.5
  • 19
    • 33645101335 scopus 로고    scopus 로고
    • Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study
    • Lakatos L, Mester G, Erdelyi Z, David G, Pandur T, Balogh M, Fischer S, Vargha P, Lakatos PL. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 2006, 12(3):205-211.
    • (2006) Inflamm Bowel Dis , vol.12 , Issue.3 , pp. 205-211
    • Lakatos, L.1    Mester, G.2    Erdelyi, Z.3    David, G.4    Pandur, T.5    Balogh, M.6    Fischer, S.7    Vargha, P.8    Lakatos, P.L.9
  • 20
    • 9844255567 scopus 로고    scopus 로고
    • Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study
    • Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997, 41(4):522-525.
    • (1997) Gut , vol.41 , Issue.4 , pp. 522-525
    • Kornfeld, D.1    Ekbom, A.2    Ihre, T.3
  • 22
    • 0035080617 scopus 로고    scopus 로고
    • The risk of colorectal cancer in ulcerative colitis: a meta-analysis
    • Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48(4):526-535.
    • (2001) Gut , vol.48 , Issue.4 , pp. 526-535
    • Eaden, J.A.1    Abrams, K.R.2    Mayberry, J.F.3
  • 23
    • 77953479589 scopus 로고    scopus 로고
    • Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer
    • Danese S, Mantovani A. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene 2010, 29(23):3313-3323.
    • (2010) Oncogene , vol.29 , Issue.23 , pp. 3313-3323
    • Danese, S.1    Mantovani, A.2
  • 24
    • 84858722471 scopus 로고    scopus 로고
    • DNA damage-dependent NF-kappaB activation: NEMO turns nuclear signaling inside out
    • McCool KW, Miyamoto S. DNA damage-dependent NF-kappaB activation: NEMO turns nuclear signaling inside out. Immunol Rev 2012, 246(1):311-326.
    • (2012) Immunol Rev , vol.246 , Issue.1 , pp. 311-326
    • McCool, K.W.1    Miyamoto, S.2
  • 26
    • 84866718513 scopus 로고    scopus 로고
    • Cell-selective inhibition of NF-kappaB signaling improves therapeutic index in a melanoma chemotherapy model
    • Enzler T, Sano Y, Choo MK, Cottam HB, Karin M, Tsao H, Park JM. Cell-selective inhibition of NF-kappaB signaling improves therapeutic index in a melanoma chemotherapy model. Cancer Discov 2011, 1(6):496-507.
    • (2011) Cancer Discov , vol.1 , Issue.6 , pp. 496-507
    • Enzler, T.1    Sano, Y.2    Choo, M.K.3    Cottam, H.B.4    Karin, M.5    Tsao, H.6    Park, J.M.7
  • 27
    • 65349168917 scopus 로고    scopus 로고
    • Cell survival from chemotherapy depends on NF-kappaB transcriptional up-regulation of coenzyme Q biosynthesis
    • Brea-Calvo G, Siendones E, Sanchez-Alcazar JA, de Cabo R, Navas P. Cell survival from chemotherapy depends on NF-kappaB transcriptional up-regulation of coenzyme Q biosynthesis. PLoS One 2009, 4(4):e5301.
    • (2009) PLoS One , vol.4 , Issue.4 , pp. e5301
    • Brea-Calvo, G.1    Siendones, E.2    Sanchez-Alcazar, J.A.3    de Cabo, R.4    Navas, P.5
  • 28
    • 79960685139 scopus 로고    scopus 로고
    • A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer
    • Perona R, Lopez-Ayllon BD, de Castro CJ, Belda-Iniesta C. A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer. Clin Transl Oncol 2011, 13(5):289-293.
    • (2011) Clin Transl Oncol , vol.13 , Issue.5 , pp. 289-293
    • Perona, R.1    Lopez-Ayllon, B.D.2    de Castro, C.J.3    Belda-Iniesta, C.4
  • 29
    • 84862012508 scopus 로고    scopus 로고
    • The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
    • Houthuijzen JM, Daenen LG, Roodhart JM, Voest EE. The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression. Br J Cancer 2012, 106(12):1901-1906.
    • (2012) Br J Cancer , vol.106 , Issue.12 , pp. 1901-1906
    • Houthuijzen, J.M.1    Daenen, L.G.2    Roodhart, J.M.3    Voest, E.E.4
  • 30
    • 67651031415 scopus 로고    scopus 로고
    • Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance
    • Gangemi R, Paleari L, Orengo AM, Cesario A, Chessa L, Ferrini S, Russo P. Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem 2009, 16(14):1688-1703.
    • (2009) Curr Med Chem , vol.16 , Issue.14 , pp. 1688-1703
    • Gangemi, R.1    Paleari, L.2    Orengo, A.M.3    Cesario, A.4    Chessa, L.5    Ferrini, S.6    Russo, P.7
  • 31
    • 16844368698 scopus 로고    scopus 로고
    • Tumour stem cells and drug resistance
    • Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005, 5(4):275-284.
    • (2005) Nat Rev Cancer , vol.5 , Issue.4 , pp. 275-284
    • Dean, M.1    Fojo, T.2    Bates, S.3
  • 32
    • 33644538632 scopus 로고    scopus 로고
    • Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli
    • Wu ZH, Shi Y, Tibbetts RS, Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 2006, 311(5764):1141-1146.
    • (2006) Science , vol.311 , Issue.5764 , pp. 1141-1146
    • Wu, Z.H.1    Shi, Y.2    Tibbetts, R.S.3    Miyamoto, S.4
  • 33
    • 0344305376 scopus 로고    scopus 로고
    • Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress
    • Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003, 115(5):565-576.
    • (2003) Cell , vol.115 , Issue.5 , pp. 565-576
    • Huang, T.T.1    Wuerzberger-Davis, S.M.2    Wu, Z.H.3    Miyamoto, S.4
  • 35
    • 84863910171 scopus 로고    scopus 로고
    • Cell Miner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set
    • Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J, Pommier Y. Cell Miner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res 2012, 72(14):3499-3511.
    • (2012) Cancer Res , vol.72 , Issue.14 , pp. 3499-3511
    • Reinhold, W.C.1    Sunshine, M.2    Liu, H.3    Varma, S.4    Kohn, K.W.5    Morris, J.6    Doroshow, J.7    Pommier, Y.8
  • 36
    • 79959935959 scopus 로고    scopus 로고
    • EGFR signaling in colorectal carcinoma
    • Krasinskas AM. EGFR signaling in colorectal carcinoma. Patholog Res Int 2011, 2011:932932.
    • (2011) Patholog Res Int , vol.2011 , pp. 932932
    • Krasinskas, A.M.1
  • 37
    • 84856641109 scopus 로고    scopus 로고
    • NF-kappaB, the first quarter-century: remarkable progress and outstanding questions
    • Hayden MS, Ghosh S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 2012, 26(3):203-234.
    • (2012) Genes Dev , vol.26 , Issue.3 , pp. 203-234
    • Hayden, M.S.1    Ghosh, S.2
  • 38
    • 84896403957 scopus 로고    scopus 로고
    • The chemokine CXCL8 in carcinogenesis and drug response
    • Gales D, Clark C, Manne U, Samuel T. The chemokine CXCL8 in carcinogenesis and drug response. ISRN Oncol 2013, 2013:859154.
    • (2013) ISRN Oncol , vol.2013 , pp. 859154
    • Gales, D.1    Clark, C.2    Manne, U.3    Samuel, T.4
  • 39
    • 0032905030 scopus 로고    scopus 로고
    • Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB
    • Wang CY, Cusack JC, Liu R, Baldwin AS. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 1999, 5(4):412-417.
    • (1999) Nat Med , vol.5 , Issue.4 , pp. 412-417
    • Wang, C.Y.1    Cusack, J.C.2    Liu, R.3    Baldwin, A.S.4
  • 42
    • 2542449068 scopus 로고    scopus 로고
    • Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit
    • Guo J, Verma UN, Gaynor RB, Frenkel EP, Becerra CR. Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit. Clin Cancer Res 2004, 10(10):3333-3341.
    • (2004) Clin Cancer Res , vol.10 , Issue.10 , pp. 3333-3341
    • Guo, J.1    Verma, U.N.2    Gaynor, R.B.3    Frenkel, E.P.4    Becerra, C.R.5
  • 43
    • 84880869807 scopus 로고    scopus 로고
    • The complexity of NF-kappaB signaling in inflammation and cancer
    • Hoesel B, Schmid JA. The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 2013, 12:86.
    • (2013) Mol Cancer , vol.12 , pp. 86
    • Hoesel, B.1    Schmid, J.A.2
  • 44
    • 84876583843 scopus 로고    scopus 로고
    • EpCAM modulates NF-kappaB signaling and interleukin-8 expression in breast cancer
    • Sankpal NV, Fleming TP, Gillanders WE. EpCAM modulates NF-kappaB signaling and interleukin-8 expression in breast cancer. Mol Cancer Res 2013, 11(4):418-426.
    • (2013) Mol Cancer Res , vol.11 , Issue.4 , pp. 418-426
    • Sankpal, N.V.1    Fleming, T.P.2    Gillanders, W.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.